A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for Major Depressive Disorder
Drug: NBI-1065845
18 locations incl. Oceanside
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18+
Code: NCT07196501·Phase 3·Recruiting